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Abstract
Successful anterior cruciate ligament reconstruction with a tendon graft necessitates solid healing
of the tendon graft in the bone tunnel. Improvement of graft healing to bone is crucial for facilitating
an early and aggressive rehabilitation and ensuring rapid return to pre-injury levels activity. Tendon
graft healing in a bone tunnel requires bone ingrowth into the tendon. Indirect Sharpey fiber
formation and direct fibrocartilage fixation confer different anchorage strength and interface
properties at the tendon-bone interface. For enhancing tendon graft-to-bone healing, we introduce
a strategy that includes the use of periosteum, hydrogel supplemented with periosteal progenitor
cells and bone morphogenetic protein-2, and a periosteal progenitor cell sheet. Future studies
include the use of cytokines, gene therapy, stem cells, platelet-rich plasma, and mechanical stress
for tendon-to-bone healing. These strategies are currently under investigation, and will be applied
in the clinical setting in the near future.
Graft healing
One of the most challenging and important problems
physicians are facing is the failure of anterior cruciate lig-
ament (ACL) reconstruction after injury and primary sur-
gical repair [1-4]. It is possible to ensure a good clinical
outcome of the primary repair in carefully selected
patients [5]. The cause of failure of the ACL has been
debated. It has been suggested that the behavior of cells
differs, suggesting that uniquely disabled fibroblasts pop-
ulate the ACL. The unsatisfactory healing is due to the fail-
ure of the cells and blood vessels within and around the
ACL to mount an adequate healing response, to bridge the
gap between the ruptured ends of the ACL, and the lack of
the wound-site to fill within the intra-articular environ-
ment [6-9].
ACL reconstruction using semitendinosus and gracilis ten-
dons has become popular in recent years. Tendon-to-bone
incorporation of the tendon graft within a bone tunnel is
a main concern when using a tendon graft for ligament
reconstruction. Successful ACL reconstruction with a ten-
don graft requires solid healing of the tendon graft in the
bone tunnel as soon as possible after surgery. Enhancing
the healing of the tendon graft to the bone is crucial to
facilitate an early and aggressive rehabilitation and a rapid
return to full activity. The basic biology of the tendon
graft-bone tunnel healing remains incompletely under-
stood. Distinct variability occurred in the morphological
characteristics of the healing at the site of attachment of
the tendon and the bone. The tendon-to-bone healing in
a bone tunnel occurs by bone ingrowth into the fibrovas-
cular interface tissue that initially forms between the ten-
don and the bone. First, progressive mineralization of the
interface tissue occurs. Subsequently, the bone grows into
the outer tendon and the tendon graft becomes incorpo-
rated into the surrounding bone. Progressive re-establish-
ment of the continuity of collagen fibers between the
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tendon and the bone results in restoration of a tendon-
bone junction [10-16].
The primary site of weakness during the early postopera-
tive period is the tendon-bone interface, particularly while
the tendon attaches to the bone within the intraarticular
environment. The osteointegration of the tendon grafts
used for the replacement of an ACL may still be unsatis-
factory and may be associated with postoperative ante-
rior-posterior laxity. The firm attachment of the tendon
graft to the bone allows earlier and more aggressive reha-
bilitation and a quicker return to full activity.
To improve the healing of the ACL graft, new strategies to
promote the intra-articular and intraosseous healing are
evolving. Although these strategies are currently under
investigation, they are expected to be clinically applied in
the near future. The strategies to improve the tendon-to-
bone tunnel healing focus on providing appropriate
molecular signaling thereby allowing cell differentiation
which result in an effective healing response between the
tendon and the bone. A sufficient population of stem cells
is required for optimal tissue regeneration. The mesenchy-
mal stem cell-treated grafts have cartilage at the tendon-
bone interface [17-20]. Bone ingrowth plays an important
role in the graft-to-bone fixation. Several strategies have
been demonstrated to improve bone ingrowth into a ten-
don graft that was placed in a bone tunnel. Most of these
strategies involved the use of osteoinductive cytokines
[21-25]. The tendon graft-to-bone healing could be
improved by the use of many factors, such as brushite cal-
cium phosphate cement, injectable tricalcium phosphate,
mesenchymal stem cells, hyperbaric oxygen treatment,
transforming growth factor-beta 1, calcium-phosphate,
bone marrow, demineralized bone matrix, synovial mes-
enchymal stem cells, granulocyte colony-stimulating fac-
tor, magnesium-based bone adhesive, bone
morphogenetic proteins-2 (BMP-2), low-intensity pulsed
ultrasound and shock wave therapy [17-32]. Osteocon-
ductive materials may also play a role in improving the
healing of the tendon in the bone tunnel via enriched
bone ingrowth [26,27,29-31]. Shock wave treatment sig-
nificantly improves the healing rate of the tendon-bone
interface resulting in significantly more trabecular bone
around the tendons [26]. Hyperbaric oxygen treatment,
low-intensity pulsed ultrasound and extracorporeal
shockwave could induce a marked increase in vascularity
that improves the formation of new bone [28,31,32].
These various methods demonstrate the challenge of
achieving a secure biologic fixation of the tendon graft in
a bone tunnel with the current ACL reconstruction tech-
niques.
Our strategy to enhance the tendon-to-bone healing is to
use the periosteum, hydrogel with periosteal progenitor
cells (PPCs) and BMP-2 and PPC sheets.
Periosteum to enhance tendon-to-bone healing
The periosteum consists of multipotent mesodermal cells.
In addition, it contains chondroprogenitor and osteopro-
genitor cells, which can form both cartilage and bone
under appropriate conditions [33-37]. The periosteal tis-
sue may be used to improve the healing between the ten-
don graft and the bone. In our experimental studies, we
evaluated the effect of periosteum-enveloping tendon
graft on tendon-to-bone healing in two different experi-
mental models in rabbits: periosteum-enveloping tendon
graft in a bone tunnel, and periosteum-enveloping tendon
graft in ACL reconstruction [38,39].
In the bone tunnel model, cross sections of the bone tun-
nel showed that the periosteal tissue formed a fibrovascu-
lar interface between the tendon and the bone. Due to the
new bone formation, the cancellous bone in the bone
tunnel interdigitated with the fibrous interface tissue four
weeks after operation. There was progressive mineraliza-
tion and maturation of the new bone that grew into the
interface fibrous layer. There appeared to be excellent inte-
gration between the fibrous interface layer and the bone
and between the tendon and the interface layer at eight
weeks after operation. Progressive collagen fiber-bone
anchoring, maturation and organization between the ten-
don and the bone lining cells occurred. In addition, fibro-
cartilage formed between the tendon and the bone [38].
In the ACL reconstruction model, radiographs showed
bone resorption as well as the formation of new bone
around the femoral and tibial bone tunnel in the perios-
teum-treated tendon graft. There was further matrix depo-
sition at the tendon-to-bone interface. Eight weeks after
operation, the periosteum-enveloping specimens demon-
strated cartilage and bone formation around the tendon
graft in the femoral and tibial tunnel. There was extensive
formation of new bone trabeculae and cartilage at the ten-
don-to-bone interface with new bone direct apposition to
the tendon [39].
The periosteum-treated tendon graft was used for ACL
reconstruction to enhance the healing of the tendon graft
in the bone tunnel. The graft was composed of double
loops of semitendinosus and gracilis tendons. A periosteal
flap was harvested from the anterior tibial cortex and
divided into two flaps. The periosteum was wrapped with
the cambium layer, placed outside to face the tunnel wall
and then sutured on the tendon at both sides where the
tendon graft approaches the tunnel opening [40](Fig. 1).
In the follow-up study, clinical assessments with the
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points before and after surgery. After reconstruction, 81%
of the patients could return to moderate or strenuous
activity. 94% of the patients were assessed as normal or
nearly normal according to the International Knee Docu-
mentation Committee (IKDC) guideline. A bone tunnel
enlargement of more than 1 mm was identified in 5% of
the femoral tunnel and 6% of the tibial tunnel [41]. The
periosteum can be easily harvested from the proximal
tibia by routine incision to harvest hamstring tendons. In
addition to its potential in improving the tendon-to-bone
healing, the enveloped-periosteum may help to seal the
intra-articular tunnel opening quickly after surgery, thus
avoiding the reflux of synovial fluid into the tunnel. Sub-
sequently, the bone tunnel enlargement could be reduced
[35](Fig. 2).
Hydrogel with PPCs and BMP-2 to enhance 
tendon graft-bone healing
PPCs have the potential to differentiate into osteogenitor
and chondrogenitor cells in an adequate microenviron-
ment. PPCs are used to enhance the tendon-to-bone heal-
ing process by forming a fibrocartilage interface. A novel
injectable hydrogel supplemented with PPCs and BMP-2
was developed for an easier delivery into the bone tunnel.
Photopolymerization allows for an impressive degree of
spatial and temporal control with implications for
diverse, minimally invasive applications for tissue regen-
eration. [42-50] PPCs require appropriate signals to differ-
entiate into cartilage and bone. BMP-induced signal
transduction is an important positive regulator. PEGDA-
based polymers (polyethyleneglycoldiacrylate) can pro-
vide a suitable microenvironment for the growth and dif-
ferentiation of mesenchymal stem cells [51-55].
Hyaluronic acid (HA) is applied for biomaterial fabrica-
tion and application to transduce intrinsic signals within
a structure and to enhance tissue formation. In addition,
it plays a crucial role in promoting cell differentiation and
cell growth [56,57]. In our experimental studies, the effect
of a hydrogel supplemented with PPCs and BMP-2 on ten-
don-to-bone healing was evaluated in two animal mod-
els: tendon graft in a bone tunnel model and tendon graft
in an ACL reconstruction model [58,59].
In the bone tunnel model, we tested the feasibility of HA
tethered to BMP-2 to stimulate PPCs to direct the fibrocar-
tilagenous attachment and new bone formation in an
extra-articular tendon-to-bone healing model. The PPC-
BMP-2 hydrogel was injected and photogelated in the
bone tunnel after placing the tendon graft into the bone
tunnel. The histological analysis showed that interface
fibrocartilage and new bone formed within six weeks. The
healing of the tendon-to-bone interface underwent a grad-
ual remodeling process. The biomechanical testing
revealed a higher maximum pull-out strength and stiff-
ness with a statistically significant difference. It appears
that photoencapsulation of BMP-2 and PPCs has a power-
ful inductive ability for the healing between tendon and
bone [58].
In the ACL reconstruction model, the PPC-BMP-2 hydro-
gel was injected and photogelated in the femoral and tib-
ial tunnel after ACL reconstruction with a flexor digitorum
longus tendon in rabbits. Histological analysis of the ten-
don-to-bone interface in the femoral and tibial tunnel
showed that an interface layer was formed by the hydro-
gel. After eight weeks, there was further matrix deposition
with fibrocartilage formation at the tendon-to-bone junc-
tion. After 12 weeks, large areas of fibrocartilage at the ten-
don-to-bone junction formed an interface. The use of the
PEGDA-based hydrogel provided an adequate matrix for
the encapsulation of cells and signal factors. In addition,
it was an effective local delivery method to reach the bone
tunnel through injection. After the hydrogel is injected, it
can be solidified via a photoinitiated polymerization
ACL reconstruction with periosteum-enveloping hamstring  tendon autograft Figure 1
ACL reconstruction with periosteum-enveloping 
hamstring tendon autograft.
MR image of the tendon graft in the bone tunnel showed  excellent incorporation Figure 2
MR image of the tendon graft in the bone tunnel 
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process which ensures encapsulation of the stem cells and
growth factors [59] (Fig. 3).
PPC sheet to enhance tendon-to-bone healing
A scaffold-free method using polymerized fibrin-coated
dishes to generate functional PPC sheets that can be used
as periosteum-like tissue transplants was developed.
Polymerized fibrin-coated polyethylene dishes were fabri-
cated with fibrinogen monomers which were mixed with
thrombin. PPCs derived from the periosteum of the tibia
of rabbits were cultivated on a fibrin-coated surface. The
laminated cell sheets were detached from the polymerized
fibrin layer by proteases secreted from the cells. The PPC
sheets were seeded onto the small intestinal submucosa
(SIS) layer. The PPC sheets could be harvested non-inva-
sively as intact, transplantable sheets by using an intrinsic
protease. The PPC sheets were wrapped around the ten-
don grafts which were then used for ACL reconstruction in
rabbits. There was further matrix deposition with forma-
tion of fibrocartilage at the tendon-to-bone junction after
eight weeks. The bioengineered PPC sheets and SIS co-
layer cell sheet act as artificial periosteum which offers a
novel therapeutic strategy to augment the healing at the
tendon-to-bone junction (Fig. 4).
Discussion
Current techniques of ACL graft reconstruction require
healing of a tendon graft in a bone tunnel. The attachment
site of the graft to the bone differs from the human anat-
omy where ligaments attach to the surface of bone. There
are no sites in the body where a tendon is surrounded by
bone such as in a bone tunnel. A common cause for an
unsatisfactory ACL reconstruction is a failure of the graft-
to-bone healing. Three fundamental factors may be
responsible for the lack of cell signaling and differentia-
tion resulting in an ineffective healing response between
the tendon and the bone. These factors include the pres-
ence of inflammation in the postnatal organism, tendon-
to-bone interface motion and an insufficient number of
undifferentiated cells at the healing tendon-to-bone inter-
face.
The successful ACL reconstruction with a tendon graft
necessitates effective healing of the tendon graft in the
femoral and tibial bone tunnel. The tendon-to-bone heal-
ing progresses via an interzone of vascular, highly cellular
fibrous tissue, which undergoes a maturation process that
lasts until its matrix consists of oriented collagen fibers
and the fibrous interface becomes indistinctable. [10,60]
The tendon-to-bone healing in a bone tunnel occurs via
bone ingrowth into the fibrovascular interface tissue that
forms between the tendon and the bone. Progressive re-
establishment of collagen fiber continuity between the
tendon and bone facilitates the formation of the tendoos-
seous junction. [2] The development of Sharpey-like col-
lagen fibers that connect the tendon graft to the bone has
been described and is viewed as the earliest sign of oste-
ointegration [61].
When a bone-patellar tendon-bone (BPTB) graft is used
for ACL reconstruction, the fixation of the graft depends
on the bone-to-bone healing. However, the length of the
patella tendon portion of most BPTB grafts is greater than
the intra-articular length of the ACL, resulting in tendon-
Injectable hydrogel to enhance the tendon graft-bone healing Figure 3
Injectable hydrogel to enhance the tendon graft-
bone healing.
Cell sheet act as artificial periosteum to ehhance the tendon- bone healing Figure 4
Cell sheet act as artificial periosteum to ehhance the 
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to-bone healing (between the tendon portion and the tib-
ial tunnel) rather than bone-to-bone healing. It is believed
that the graft fixation strength is lower and the healing is
poorer in the tendon graft compared with the bone plug
healing in the tunnel. In the tendon graft, the weakest site
was the graft-wall interface at three weeks and the intraos-
seous tendon graft at six weeks [62].
Spatial and temporal differences in the tendon-to-bone
healing exist in the different regions of the bone tunnel.
The healing of the tendon-to-bone interface tissue shows
a wide chondroid matrix at the intra-articular aperture, in
contrast to a narrow, fibrous matrix at the intra-osseous
portion. The collagen continuity between the tendon graft
and the bone tunnel increased over time, with a more par-
allel orientation and increased collagen fiber continuity
between the tendon and the bone. Significant differences
in the healing between the tendon graft and the bone exist
throughout the length of bone tunnel. The etiology of
these differences includes a variable biological and bio-
mechanical environment at different sites of the tunnel.
[63] Adequate mechanical loading on the tendon graft
should be one of the basic requirements for long-time sur-
vival of the graft tissue. The tendon healing in a bone tun-
nel is influenced by mechanical stress. It has been shown
that the differentiation of mesenchymal stem cells is
directly influenced by pressure and tension. In the bone
tunnel, mechanical loading occurs mainly by shear forces,
which might prevent or delay the development of a fibro-
cartilage zone and leads to the development of an indirect
insertion [64].
On the basis of a normal ACL structure and the known
function of the insertion site, the ideal tendon graft would
attach broadly to the surface of the bone at the site of the
femur and tibia by an intermediate zone of fibrocartilage.
The periosteum contains multipotent mesodermal cells. It
has been shown that the environment has an influence on
the differentiation of cells in free periosteal grafts [40].
The periosteum has osteogenic capacity and can promote
the formation of cartilage in a chondrotrophic environ-
ment. The periosteum has also the ability to initiate the
formation of endochondral bone by inducing the differ-
entiation of mesenchymal cells into chondroblasts and
subsequently into osteoblasts. In addition, the perios-
teum can also augment bone ingrowth into the collagen-
ous tissue thereby inducing ossification and bone
formation. Free autologous periosteal transplants have
been reported to produce hyaline-like cartilage in chon-
dral defects of the patella, which suggests the potential of
stem cells in the cambium layer to produce cartilage [65].
Thus, based on the findings of these studies, if the perios-
teum is applied to the surface of a tendon graft it should
form cartilage or bone tissue. In addition, if the perios-
teum-enveloping tendon graft is placed extra- or intraar-
ticularly in a tunnel, it may promote the initiation and
regulation of the bone ingrowth into the tendon graft.
The cambium layer serves as a fibrous layer between ten-
don and bone when the periosteum is sutured on the sur-
face of the tendon and transplanted into a bone tunnel.
The bone ingrowth into the cambium layer as well as the
interdigitation between the periosteal tissue and tendon
can be observed after four weeks. The interface of the
fibrous layer, which originates from the wrapped perios-
teum, becomes progressively incorporated. The organiza-
tion of the interface develops over time. There is an
extensive formation of fibrocartilage at the tendon-bone
interface. The periosteum has the powerful inductive abil-
ity to enhance the healing between the tendon and the
bone tunnel. The periosteum can induce the differentia-
tion of mononuclear cells into chondroblastic and oste-
oblastic cells. Subsequently, it directs the production of
fibrocartilage or osteoid followed by mineralization and
progressive remodeling which occurs during the healing
process [38]. The periosteum has a rapid effect on bone
ingrowth thereby enhancing the strength of the fixation.
The enveloping of the tendon graft with the periosteum
may be an effective way to avoid delayed graft healing.
The periosteum may be even more effective in situations
in which healing is impaired, e.g. in those with a widened
bone tunnel in a revision operation.
The expansion of the tunnel is significantly greater follow-
ing ACL reconstruction using hamstring tendon
autografts. This is because of the greater distance between
the normal insertion site and the biomechanical point of
action of the ACL. The greater distance creates a poten-
tially larger force moment during graft cycling which may
lead to the greater expansion of the bone tunnel [66]. Ade-
quate and earlier tendon-to-bone healing may solve this
problem. This technique may be applied to ACL recon-
struction to enhance the tendon graft healing within the
tunnel.
In order to enhance the tendon-to-bone tunnel healing,
our laboratory intended to develop an injectable hydrogel
to fill the tendon-bone tunnel interface in a tissue-engi-
neering approach. Tissue-engineering therapies for biomi-
metic material rely on the stimulation of signaling growth
factors to induce cellular chemotaxis, proliferation, differ-
entiation and a notable formation of new tissue at the
required site. Recent studies have shown that various
growth factors play important roles in tissue repair both in
vivo and in vitro [26,61,67-72]. Therefore, photopolymer-
izable hydrogel supplemented with PPC and BMP-2
would also enhance the formation of an interpenetrating
network that may limit the tunnel enlargement and
improve the healing response of the graft in the tunnel.Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2009, 1:21 http://www.smarttjournal.com/content/1/1/21
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Photopolymerized hydrogel is used as scaffold material in
tissue-engineering techniques and typically serves as car-
rier or filler in biological systems. Scaffolds should, in
part, mimic the structure and biological function of an
extracellular matrix. They should promote cell prolifera-
tion, induce cell differentiation or enhance the growth of
surrounding tissues. Numerous biological molecules have
been used as functional additives in hydrogel to enhance
the development of engineered tissues. Biological mole-
cules, such as growth factors, together with cells can be
physically encapsulated in the hydrogel [57]. In addition,
growth factors can be covalently tethered to the hydrogel
to prevent their loss by leaching or extraction [73]. This
tethering offers prolonged retention of those growth fac-
tors to induce the relevant signaling pathways. The addi-
tion of BMP-2 to the hydrogel for its delivery to the target
site is essential to allow BMP-2 to act there. Photoencap-
sulation of BMP-2 in a PEGDA-based hydrogel provides
the temporally and spatially defined modulation of chon-
droblastic and osteoblastic differentiation. Consistent
stimulation by prolonged BMP-2 retention enhances the
migration and proliferation of PPCs. However, several
critical problems must be addressed before the clinical
application of this technique, such as dose determination,
a simple and reliable delivery, the maintaining of the
effect in the tunnel and the cost effectiveness of this appli-
cation.
Based on the finding that the tendon-to-bone healing
progresses by bone ingrowth into the fibrous tissue inter-
zone, exogenous osteoinductive agents should be used to
augment this process. We demonstrated improved heal-
ing by applying injectable photopolymerizable hydrogel
at the tendon-to-bone interface [44,74]. Our study sug-
gests that photoencapsulation of BMP-2 and PPCs has the
ability to improve the healing between the tendon and the
bone. This technique may provide a novel platform for tis-
sue-engineered stem cell therapy.
Cell therapy for tissue regeneration together with tissue
engineering technology develops rapidly. Functional cell
sheets for transplants are formed by cells. Biomaterials
serve as cell carrier. The cell sheets can be easily detached
and maintain the complete connective matrix in cells, cell
phenotype, proliferation and differentiation. In our study,
periosteum-like cell sheets were formed for orthopedic tis-
sue regeneration. The PPCs and chondrocytes were used
to produce periosteum-like cell sheets. The PPC carriers
were prepared by polymerization of fibrinogen mono-
mers mixed with thrombin. Natural acellular SIS was used
as delivery vehicle for the cell sheets. The PPC sheets were
placed onto a SIS layer thereby forming an artificial perio-
steal bilayer. The PPC sheets were wrapped around the
tendon graft and placed into the bone tunnel. Histology
showed higher matrix deposition with fibrocartilage for-
mation at the tendon-bone junction after four weeks. Our
results suggest that well-organized and functional PPC
sheets maintain their differentiated capacity and keep
their ex vivo osteochondral potential. The PPC sheets
could act as periosteum to offer a novel approach to
enhance the healing at the tendon-bone junction.
Conclusion
Successful ACL reconstruction with a tendon graft requires
solid healing of the tendon graft in the bone tunnel.
Recent improvements in ACL reconstruction techniques
have highlighted the importance of new biologic strate-
gies to promote the intraarticular and intraosseous heal-
ing. Future techniques to improve the tendon-to-bone
healing may include the use of cytokines, which will pro-
vide important signals for tissue formation and differenti-
ation, gene therapy techniques, which will ensure the
prolonged presence of molecules important for the heal-
ing process, stem cells, which will help produce a popula-
tion of undifferentiated cells, and transcription factors,
which will help direct nuclear gene expression. In addi-
tion, platelet-rich plasma or platelet gel from autologous
blood facilitates delivery of serum-derived cytokines. Sev-
eral techniques are being developed to inhibit the expres-
sion of molecules that might prohibit successful healing.
Furthermore, modulation of the biomechanical environ-
ment may have profound effects on the cellular and
molecular events at the healing tendon-bone interface
[62]. These biologic strategies are currently under investi-
gation, and will be applied in the clinical setting in the
near future.
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